Health Care: Drugs

Cytori Therapeutics Inc (CYTX: NASDAQ)

$0.38 0.0179 | 4.94%
09/01/15 - 04:00 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 7.60M 12.20M 14.50M 7.98M
Cost of Sales 941.00K 898.00K 2.14M 2.27M
Gross Operating Profit 6.66M 11.30M 12.36M 5.71M
Selling, General, and Administrative Expenses 22.36M 25.06M 25.16M 28.29M
Research & Development 15.10M 17.06M 13.63M 10.90M
Operating Income before D & A (EBITDA) -30.81M -30.82M -26.42M -33.48M
Depreciation & Amortization 2.00M 2.52M 1.86M 1.57M
Interest Income 6.00K 4.00K 4.00K 9.00K
Other Income - Net -566.00K 7.94M -314.00K 1.22M
Special Income / Charges 369.00K 2.67M -131.00K 4.36M
Total Income Before Interest Expenses (EBIT) -33.00M -22.78M -28.89M -29.67M
Interest Expense 4.37M 3.40M 3.39M 2.78M
Pre-Tax Income -37.37M -26.18M -32.28M -32.45M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -37.37M -26.18M -32.28M -32.45M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -37.37M -26.18M -32.28M -32.45M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -37.37M -26.18M -32.28M -32.45M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-37.74M -28.84M -32.15M -36.81M
Preferred Dividends
Net Income Available To Common -38.54M -26.18M -32.28M -32.45M
Basic EPS from Continuing Ops. -0.48 -0.39 -0.55 -0.61
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.48 -0.39 -0.55 -0.61
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.48 -0.39 -0.55 -0.61
Basic Normalized Net Income/Share -0.48 -0.43 -0.55 -0.69
EPS fr Continuing Ops. -0.48 -0.39 -0.55 -0.61
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.48 -0.39 -0.55 -0.61
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.48 -0.39 -0.55 -0.61
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.48 -0.43 -0.55 -0.69
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with CYTX

Latest CYTX Headlines from TheStreet

More Financial News for CYTX

Press Releases for CYTX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter